The grey market premium of the Molbio Diagnostics IPO, day by day, against the ₹807 upper price band. Last figure from 17 Aug 2026.
The GMP of the Molbio Diagnostics IPO started at ₹0 on 4 Aug 2026 and ended ₹116 before listing, up ₹116 over 14 days.
It peaked at ₹220 on 6 Aug 2026 and was lowest at ₹0 on 4 Aug 2026. In the last 4 days it rose by ₹1.
From one recorded day to the next, the GMP rose on 7 days and fell on 6 days. The largest one-day move was a rise of ₹170 on 5 Aug 2026.
On the day bidding opened, 10 Aug 2026, the GMP was ₹127; on the day it closed, 12 Aug 2026, it was ₹154.
Bidding closed with the issue subscribed 70.27× overall.
At the ₹807 upper band, the last GMP pointed to a 14.37% gain; the shares listed up 21.44%, so the GMP understated the gain.
One lot is 18 shares, ₹14,526 at the ₹807 upper band.
The last GMP pointed to a gain of ₹2,088 on one lot. The shares listed at about ₹980.02, which made a gain of ₹3,114 on one lot.
At the highest GMP, ₹220, the figure for one lot was a gain of ₹3,960; at the lowest, ₹0, it was no gain.
GMP last updated: 17 Aug 2026, 8:53 AM IST
| Date | GMP | Over issue price | Implied listing | Change |
|---|---|---|---|---|
| 17 Aug 2026 | ₹116 | 14.37% | ₹923 | −₹4 |
| 16 Aug 2026 | ₹120 | 14.87% | ₹927 | −₹5 |
| 15 Aug 2026 | ₹125 | 15.49% | ₹932 | +₹10 |
| 14 Aug 2026 | ₹115 | 14.25% | ₹922 | −₹41 |
| 13 Aug 2026 | ₹156 | 19.33% | ₹963 | +₹2 |
| 12 Aug 2026 | ₹154 | 19.08% | ₹961 | +₹16 |
| 11 Aug 2026 | ₹138 | 17.1% | ₹945 | +₹11 |
| 10 Aug 2026 | ₹127 | 15.74% | ₹934 | −₹5 |
| 9 Aug 2026 | ₹132 | 16.36% | ₹939 | +₹2 |
| 8 Aug 2026 | ₹130 | 16.11% | ₹937 | −₹50 |
| 7 Aug 2026 | ₹180 | 22.3% | ₹987 | −₹40 |
| 6 Aug 2026 | ₹220 | 27.26% | ₹1027 | +₹50 |
| 5 Aug 2026 | ₹170 | 21.07% | ₹977 | +₹170 |
| 4 Aug 2026 | ₹0 | 0% | ₹807 | – |
GMP is an unofficial price from the grey market before the shares list. It is not a guarantee of the listing price and can move sharply from one day to the next. Read how we collect it in our methodology.